PBAC Public Summary Documents - November 2011
Public summary documents relating to the November 2011 PBAC meeting
Page last updated: 02 November 2012
- Abiraterone, tablet, 250 mg (as acetate), Zytiga® - November 2011
- Botulinum toxin type A purified neurotoxin complex, lyophilised powder for I.M injection, 100 units, Botox® - November 2011
- Cabazitaxel, injection set containing 1 single use vial concentrate for I.V. infusion, 60 mg (anhydrous) in 1.5 mL with diluent, Jevtana® - November 2011
- Epoprostenol sodium, powder for I.V. infusion, 500 micrograms (base) with diluent, 1.5 mg (base) with diluent, Flolan® - November 2011
- Everolimus, tablets, 5 mg and 10 mg, Afinitor® - November 2011
- Ivabradine, tablets (film-coated), 5 mg and 7.5 mg (as hydrochloride), Coralan® - November 2011
- Lacosamide, tablets, 50 mg, 100 mg, 150 mg and 200 mg, Vimpat® - November 2011
- Linagliptin, tablet, 5 mg, Trajenta® - November 2011
- Liraglutide (rys), injection solution, pre-filled pen, 6 mg per mL, 3 mL, 2 and 3 pen pack, Victoza® - November 2011
- Mannitol, capsule containing powder for oral inhalation, 40 mg (for use in inhaler device), Bronchitol® - November 2011
- Miglustat, capsule, 100 mg, Zavesca® - November 2011
- Mycophenolate sodium, tablet (enteric coated), 180 mg and 360 mg (mycophenolic acid), Myfortic® - November 2011
- Pertussis vaccine-acellular combined with diphtheria and tetanus toxoids (Adsorbed), 0.5 mL, Adacel® - November 2011
- Plerixafor, solution for injection, 20 mg in 1 mL, 1.2 mL, Mozobil® - November 2011
- Prucalopride, tablets (film-coated), 1 mg and 2 mg (as succinate), Resotrans® - November 2011
- Quadrivalent human papillomavirus (Types 6, 11, 16, 18) recombinant vaccine, solution for injection, 0.5 mL, solution for injection pre-filled syringe single dose, Gardasil® - November 2011
- Quetiapine, tablets (modified release), 50 mg, 150 mg, 200 mg, 300 mg and 400 mg (as fumarate), Seroquel XR® - November 2011
- Rifaximin, tablet (film-coated), 550 mg, Xifaxan® - November 2011
- Rilpivirine, tablet (film-coated), 25 mg (as hydrochloride), Edurant® - November 2011
- Sapropterin dihydrochloride, soluble tablet, 100 mg (equivalent to 77 mg of sapropterin), Kuvan® - November 2011
- Tadalafil, tablet, 20 mg, Adcirca® - November 2011
- Telaprevir, tablet (film coated), 375 mg, Incivo® - November 2011
- Tenofovir with emtricitabine and rilpivirine, tablet containing tenofovir disoproxil fumarate 300 mg with emtricitabine 200 mg and rilpivirine hydrochloride 25 mg, Eviplera® - November 2011
- Testosterone, solution for topical administration, 110 mL metre-dose pump, 30 mg per 1.5mL, Axiron® - November 2011
- Tocilizumab, concentrate for injection, 80 mg in 4 mL, 200 mg in 10 mL and 400 mg in 20 mL, Actemra® - November 2011
- Velaglucerase alfa, powder for IV infusion, 400 units in 4 mL, VPRIV® - November 2011
- Vinflunine, solution concentration for I.V. infusion, 50 mg in 2 mL and 250 mg in 10 mL (as ditartrate), Javlor - November 2011
